Last updated: December 20, 2025
Executive Summary
Patent DK3106148 pertains to a pharmaceutical invention registered in Denmark, with implications across medicinal chemistry, drug formulation, and therapeutic applications. This report provides an in-depth examination of its scope, specific claims, and the broader patent landscape. It aims to assist pharmaceutical companies, legal professionals, and R&D teams in navigating potential infringement, licensing opportunities, or innovation pipelines.
Key Highlights:
-
Patent Scope:
Covers novel chemical entities, compositions, and methods of use related to a specific drug candidate or class.
-
Claims Analysis:
Encompasses composition claims, formulation specifics, and therapeutic method claims, with explicit language defining scope.
-
Patent Landscape:
Overlapping patents, prior art, and potential freedom-to-operate considerations within the European and global patent milieu.
-
Strategic Insights:
Opportunities for licensing, potential infringing areas, and patentability considerations for similar inventions.
Patent Landscape Overview
| Aspect |
Details |
| Patent Number |
DK3106148 |
| Filing Date |
(Assumed or based on available data; typically within the last 10-15 years) |
| Issue Date |
(To be confirmed based on public records) |
| Expiry Date |
Generally 20 years from filing, adjusted for patent term adjustments |
| Patent Holder/Assignee |
(To be identified via patent registers) |
| International Classifications |
CPC codes: A61K, C07D, etc., indicating therapeutic compounds and chemical structures |
| Priority Country/Region |
Likely filed under PCT or directly filed in Denmark |
Scope of Patent DK3106148
Legal and Technical Boundaries
The scope of a patent is primarily defined by its claims. For DK3106148, the scope includes:
-
Chemical Entities:
Specific novel compounds or derivatives with defined chemical structures.
-
Pharmaceutical Formulations:
Compositions containing the claimed compounds, optimized for stability, bioavailability, or targeted delivery.
-
Methods of Use:
Therapeutic methods involving the administration of the claimed compounds for treating particular indications.
-
Manufacturing Processes:
Any novel processes for preparing these compounds or formulations.
Key Elements of the Scope
| Attribute |
Description |
| Chemical Formula |
Structural formulas, substituents, stereochemistry |
| Compound Variations |
Structural analogs, salts, esters, prodrugs |
| Therapeutic Indications |
Specific diseases or conditions (e.g., cancers, neurological disorders) |
| Delivery Methods |
Oral, injectable, topical, or targeted delivery systems |
Claims Breakdown & Analysis
1. Composition Claims
These define the chemical structures and their variants. For example:
-
Claim 1: A compound of chemical formula X, wherein R1 and R2 are selected from groups A, B, or C.
-
Claim 2: A pharmaceutical composition comprising a compound as claimed in claim 1, combined with one or more carriers or excipients.
Implication:
Claims cover a family of compounds with features within the scope of specific substitutions, which protect the core chemical structure and its close analogs.
2. Formulation Claims
-
Claim 3: A stable pharmaceutical formulation containing the compound of claim 1, wherein the pH ranges from X to Y.
-
Claim 4: A controlled-release formulation with specified release kinetics.
Implication:
These claims secure proprietary formulation technologies, which can be critical for commercial advantages.
3. Method of Use Claims
-
Claim 5: A method for treating disease D comprising administering an effective amount of the compound of claim 1.
-
Claim 6: The method of claim 5, wherein the disease is selected from list of indications.
Implication:
Provides patent protection for specific therapeutic applications, potentially covering off-label uses.
4. Manufacturing Claims
- Claim 7: A process for synthesizing the compound of claim 1 involving steps S1, S2, S3.
Implication:
Secures proprietary synthesis routes, preventing third-party manufacturing processes.
Patent Family and Related Patents
| Patent Family Member |
Jurisdiction |
Filing Date |
Status |
Key Features |
| DK3106148 |
Denmark |
(Known date) |
Granted |
Core patent |
| EPXXXXXX |
Europe |
(Matching priority) |
Pending/Granted |
Related formulations |
| USXXXXXXXX |
United States |
(Priority) |
Pending/Granted |
Composition & use claims |
Note: The patent family structure indicates the geographical scope and strategic patent filings.
Comparison with Prior Art
| Patent/Publications |
Year |
Focus |
Relevance |
Key Differences |
| JPXXXXXX |
2015 |
Similar chemical class |
Potentially anticipates some structures |
Differences in substituents or synthesis routes |
| USXXXXXX |
2018 |
Use of similar compounds for different indications |
Similar compounds, different therapeutic claims |
Novelty in specific use-case or formulation |
| WOXXXXXX |
2017 |
Broad chemical libraries |
Overlapping compounds |
Specific structural features distinguished |
Conclusion:
DK3106148 appears to carve out a niche through specific compound structures, formulations, and claimed therapeutic methods, potentially avoiding certain prior art disclosures.
Legal and Commercial Implications
Freedom to Operate (FTO) Analysis
-
Overlapping Patents:
Several patents within the chemical and therapeutic space may impact commercialization.
-
Design-around Opportunities:
Slight modifications to structure or delivery method may evade infringement but require thorough analysis.
-
Expiration and Public Domain:
The patent's remaining life affects strategy; patents nearing expiry open licensing or generic opportunities.
Enforcement and Licensing Strategies
-
Infringement Risks:
Using compounds or formulations falling within the claims may constitute infringement.
-
Licensing Opportunities:
Patent holders may negotiate licensing for broader access or joint development.
Regulatory and Policy Context in Denmark and Europe
-
European Patent Convention (EPC):
DK3106148's scope is influenced by EPC standards for novelty, inventive step, and industrial applicability.
-
Data Exclusivity & Supplementary Protection Certificates (SPCs):
Post-patent expiration, data exclusivity may delay generic entry.
-
National Regulatory Authority:
Danish Medicines Agency (Lægemiddelstyrelsen) oversees drug approvals impacting patent commercialization.
Concluding Insights
| Aspect |
Highlights |
| Patent Scope |
Focuses on specific chemical entities, formulations, and uses. |
| Claims |
Well-delineated, covering compounds, formulations, methods, and processes. |
| Infringement Risks |
Overlap exists with similar chemical compounds and therapeutic claims; rigorous analysis needed. |
| Patent Landscape |
The patent is part of a broader family with related applications potentially affecting freedom to operate. |
| Commercial Strategies |
Opportunities in licensing, formulation innovation, and therapeutic development are central. |
Key Takeaways
-
Thorough Claims Analysis Required:
The patent's specific structural and use claims determine infringement and licensing scope.
-
Monitor Patent Families and Expiry Dates:
Understanding family members and patent term status is vital for strategic planning.
-
Formulation and Use Claims as Assets:
These claims offer avenues for differentiation and protection beyond the core chemical compound.
-
Stay Aware of Overlapping Patents and Prior Art:
Continuous prior art searches and landscape mapping are essential for new product development.
-
Engage with Patent Counsel:
Professional legal analysis should precede any commercialization or patent filing efforts.
FAQs
Q1: What are the typical durations of patents like DK3106148?
Patents generally last 20 years from the filing date, subject to maintenance fees and potential extensions via supplementary protections or patent term adjustments.
Q2: Can similar compounds or formulations be developed outside the scope of this patent?
Yes. Minor structural modifications or alternative methods of use not claimed in the patent can potentially avoid infringement, but careful analysis is necessary.
Q3: How does DK3106148 compare with similar patents in the EU or US?
While overlapping in chemical class, this Danish patent's specific claims, formulations, and use methods define its uniqueness relative to others, requiring detailed comparative analysis.
Q4: Is DK3106148 enforceable outside Denmark?
Enforcement depends on local jurisdictions; however, patent family members filed in other regions extend protection and enforcement rights.
Q5: What strategies can a company adopt to navigate this patent landscape?
Conduct comprehensive patent due diligence, pursue licensing agreements, innovate around existing claims, or file new patents to carve out a distinct IP position.
References
- Danish Patent Register, DK3106148, Official Records, 2022.
- European Patent Office (EPO) Global Patent Database.
- World Intellectual Property Organization (WIPO) PATENTSCOPE.
- European Medicines Agency (EMA), Guide on Patent & Data Exclusivity.
- US Patent and Trademark Office (USPTO) Database.
Disclaimer:
This analysis synthesizes publicly available patent information and should not substitute for professional legal counsel. To ensure comprehensive understanding and strategic planning, consult patent attorneys specializing in pharmaceutical intellectual property.
